GPX-150|GPX 150;CNDO-101;DIDOX;5-imino-13-deoxy-doxorubicin

Cas No.:	236095-29-7
Chemical Name:	(8R,10S)-10-(((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyethyl)-12-imino-1-methoxy-7,9,10,12-tetrahydrotetracen-5(8H)-one
Synonyms:	GPX 150;CNDO-101;DIDOX;5-imino-13-deoxy-doxorubicin
SMILES:	C1=CC2C(=O)C3=C(O)C4C[C@](O)(CCO)C[C@@H](O[C@H]5O[C@H](C)[C@@H](O)[C@H](N)C5)C=4C(O)=C3C(=N)C=2C(OC)=C1
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

A doxorubicin analog that demonstrates anti-cancer activity without cardiotoxicity, does not inhibit topoisomerase IIβ activity at 100 uM

Cat. No.	Product name	Field of application
DC8923	AS-1413(Amonafide)	Amonafide(AS1413) produces protein-associated DNA-strand breaks through a topoisomerase II-mediated reaction, but does not produce topoisomerase I-mediated DNA cleavage.
DC11932	GPX-150	A doxorubicin analog that demonstrates anti-cancer activity without cardiotoxicity, does not inhibit topoisomerase IIβ activity at 100 uM.